rs139078977
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_032776.3(JMJD1C):c.2628T>C(p.Leu876Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000582 in 1,611,036 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0032 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 3 hom. )
Consequence
JMJD1C
NM_032776.3 synonymous
NM_032776.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.842
Publications
0 publications found
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
JMJD1C Gene-Disease associations (from GenCC):
- 22q11.2 deletion syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: Illumina
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 10-63213539-A-G is Benign according to our data. Variant chr10-63213539-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 460232.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.842 with no splicing effect.
BS2
High AC in GnomAd4 at 490 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| JMJD1C | ENST00000399262.7 | c.2628T>C | p.Leu876Leu | synonymous_variant | Exon 8 of 26 | 5 | NM_032776.3 | ENSP00000382204.2 | ||
| JMJD1C | ENST00000542921.5 | c.2082T>C | p.Leu694Leu | synonymous_variant | Exon 7 of 25 | 1 | ENSP00000444682.1 | |||
| JMJD1C | ENST00000402544.5 | n.2600T>C | non_coding_transcript_exon_variant | Exon 5 of 22 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00323 AC: 491AN: 152224Hom.: 3 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
491
AN:
152224
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000754 AC: 188AN: 249180 AF XY: 0.000614 show subpopulations
GnomAD2 exomes
AF:
AC:
188
AN:
249180
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000307 AC: 448AN: 1458694Hom.: 3 Cov.: 33 AF XY: 0.000266 AC XY: 193AN XY: 724920 show subpopulations
GnomAD4 exome
AF:
AC:
448
AN:
1458694
Hom.:
Cov.:
33
AF XY:
AC XY:
193
AN XY:
724920
show subpopulations
African (AFR)
AF:
AC:
389
AN:
33428
American (AMR)
AF:
AC:
15
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26108
East Asian (EAS)
AF:
AC:
0
AN:
39544
South Asian (SAS)
AF:
AC:
2
AN:
86226
European-Finnish (FIN)
AF:
AC:
0
AN:
53390
Middle Eastern (MID)
AF:
AC:
1
AN:
5760
European-Non Finnish (NFE)
AF:
AC:
6
AN:
1109292
Other (OTH)
AF:
AC:
35
AN:
60248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
23
45
68
90
113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00322 AC: 490AN: 152342Hom.: 3 Cov.: 32 AF XY: 0.00317 AC XY: 236AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
490
AN:
152342
Hom.:
Cov.:
32
AF XY:
AC XY:
236
AN XY:
74494
show subpopulations
African (AFR)
AF:
AC:
475
AN:
41586
American (AMR)
AF:
AC:
9
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68034
Other (OTH)
AF:
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
26
52
79
105
131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Early myoclonic encephalopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.